Altintas DA, Hilberg O, Hess S, Jensen TT, Bladbjerg EM, Juhl CB
A: Nausea and occasional vomiting are most common, especially when starting treatment or increasing doses
There have been at least ten deaths linked to this condition among GLP-1 drug users in the UK
Strategic cycling alternates periods on medication (typically 3-6 months) with periods attempting lifestyle-only maintenance
Similarly, CPGs might explore modular SKUs where, for example, a base drink comes with functional ingredients that consumers add to customise their product based on their own unique body chemistry
Show me an example of how GLP1s are impacting the health care space